SERELAXIN IN THE STRATEGY OF MANAGEMENT THE PATIENTS WITH ACUTE DECOMPENSATED HEART FAILURE: FROM DECREASING OF SYMPTOMS TO THE IMPROVEMENT OF SURVIVAL
In this review data of clinical investifation of serelaxin were briefly outlined. In these trials administration of serelaxin just after admission in the hospitals was acoompanied by middle-term improvement of survival of patients with acute heart failure.
Saved in:
| Main Authors: | I. V. Zhirov, S. N. Tereschenko |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
InterMedservice
2015-09-01
|
| Series: | Евразийский Кардиологический Журнал |
| Subjects: | |
| Online Access: | https://www.heartj.asia/jour/article/view/5644 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
CLINICAL CASE OF USAGE OF SERELAXIN IN THE PATIENT WITH ACUTE DECOMPENSATED HEART FAILURE
by: I. V. Zhirov, et al.
Published: (2016-04-01) -
Organoprotective effects of serelaxin in patients with severe decompensated heart failure
by: Z. D. Kobalava, et al.
Published: (2016-09-01) -
CLINICAL AND ECONOMICAL ASPECTS OF NOVEL APPROACHES TO THE TREATMENT OF CHRONIC HEART FAILURE DECOMPENSATION
by: S. K. Zyryanov, et al.
Published: (2015-03-01) -
ГЕПАТОЦИТАРНЫЙ АПОПТОЗ В РАЗВИТИИ ОСТРОЙ ХРОНИЧЕСКОЙ ПЕЧЕНОЧНОЙ НЕДОСТАТОЧНОСТИ ПРИ ДЕКОМПЕНСИРОВАННОМ АЛКОГОЛЬНОМ ЦИРРОЗЕ ПЕЧЕНИ
by: Ольга Петровна Дуданова, et al.
Published: (2025-04-01) -
EXTRACORPOREAL MEMBRANE OXYGENATION IN INTENSIVE CARE
by: Роман Александрович Корнелюк, et al.
Published: (2016-12-01)